Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome

Clinical trial NCT02060409 · COMPLETED

Trial details

NCT number: NCT02060409
Sponsor: Samsung Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndrome

Start date: 2012-01-01
Primary completion: 2013-10-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.